Amanote Research
Register
Sign In
Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.08.627
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2016
Authors
E Hanna
C Rémuzat
M Toumi
Publisher
Elsevier BV
Related search
Php307 - Reimbursement of Advanced Therapy Medicinal Products in Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Expanding Role of the Clinical Haematologist in the New World of Advanced Therapy Medicinal Products
British Journal of Haematology
Hematology
Recent Progress in European Advanced Therapy Medicinal Products and Beyond
Frontiers in Bioengineering and Biotechnology
Bioengineering
Biomedical Engineering
Histology
Biotechnology
Analysis of Existing Guidelines and Controlled Clinical Trials for Development of [Guideline of Clinical Trials With Herbal Medicinal Products for Colorectal Cancer]
Journal of Korean Medicine
Genome‐edited Adult Stem Cells: Next‐generation Advanced Therapy Medicinal Products (ATMPs)
Stem cells translational medicine
Medicine
Developmental Biology
Cell Biology
Psy166 - Market Access Trends for Advanced Therapy Medicinal Products (Atmps) in Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Discontinuation of Pediatric Trials
Archivos Argentinos de Pediatria
Child Health
Pediatrics
Perinatology
Clinical Translation of Tissue Engineered Medicinal Products
Journal of Stem cell & Regenerative Biology
A Dozen Years of Clinical Trials Performing Advanced Cell Therapy With Perinatal Cells
Future Science OA
Medicine
Biotechnology
